Verastem | VSTM - Валовая прибыль





Валовая прибыль Изменить Дата
AbbVie USD 14.39B 1.85B 2026-06
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
AstraZeneca USD 12.86B 251M 2026-06
Curis USD 1.14M 8.86M 2025-12
Cytokinetics USD 23.03M 3.84M 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
Incyte USD 1.57B 400.89M 2026-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Roche Holding CHF 22.69B 600M 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06
Verastem USD 15.62M 977K 2026-03